GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (Gadoterate Meglumine) in Pre-Filled Syringes View more
Monteris Medical Announces Favorable 12-Month Outcomes for Patients Receiving Minimally Invasive Laser Ablation for Brain Tumors View more